BCBS Tennessee Medical Policy Updates – July 2019

Click here to view the Blue Cross Blue Shield Tennessee Medical Policy Updates »

July 2019 BCBS Tennessee Medical Policy Updates:

• Ablation Procedure for Peripheral Neuromas
• Ado-Trastuzumab Emtansine
• Aldesleukin
• Atezolizumab
• Autonomic Nervous System Testing
• Avelumab
• Axicabtagene Ciloleucel
• Belinostat
• Bendamustine HCl (Bendeka®)
• Bendamustine HCl (Treanda®)
• Bevacizumab for the Treatment of Neoplastic Disease
• Biochemical Markers for Alzheimer’s Disease
• Bortezomib
• Bortezomib
• Brentuximab Vedotin
• Burosumab-twza
• Cemiplimab-rwlc
• Cetuximab
• Computed Tomography to Detect Coronary Artery Calcification (i.e., calcium scoring)
• Corticotropin Therapy
• Durvalumab
• Eculizumab
• Edaravone
• Elosulfase Alfa
• Elotuzumab
• Eteplirsen
• Gender Reassignment Surgery
• Genetic Testing for Mental Health Conditions
• Genetic Testing for Mitochondrial Disorders
• Genotyping for 9p21 Single Nucleotide Polymorphisms to Predict Risk of Cardiovascular Disease or Aneurysm
• Hemodialysis in the Home
• Home Pulse Oximetry
• Human Amniotic Membrane Grafts and Amniotic Fluid Injections
• Immune Cell Function Assay
• Inotersen
• Ipilimumab
• Magnetic Resonance Imaging (MRI) of the Breast
• Mammography Screening
• Nivolumab
• Non-Contact Ultrasound Treatment for Wounds
• Non-invasive Positive Pressure Ventilators (In-Home Use)
• Nusinersen
• Obinutuzumab
• Omacetaxine Mepesuccinate
• Osteochondral Autografting (OCG)
• Ovarian Cancer Tumor Markers
• Panitumumab
• Patisiran
• Bevacizumab for the Treatment of Neoplastic Disease
• Olaratumab
• Trastuzumab-dkst
• Pelvic Floor Stimulation
• Pembrolizumab
• Pemetrexed
• Pertuzumab
• Pneumatic Compression Pumps for the Treatment of Lymphedema, DVT Prophylaxis and Venous Ulcers in the Home Setting
• Pralatrexate
• Prostatic Urethral Lift
• Proton or Helium Ion Beam (Charged Particle) Radiation Therapy
• Radiofrequency Ablation of the Renal Sympathetic Nerves as a Treatment for Resistant Hypertension
• Radiofrequency Tissue Volume Reduction (RFTVR) for the Treatment of Upper Airway Obstruction
• Ramucirumab
• Rituximab
• Rituximab-abbs
• Romidepsin
• Romiplostim
• Sargramostim
• Siltuximab
• Spinal Unloading Devices for the Treatment of Low Back Pain
• Tagraxofusp-erzs
• Temsirolimus
• Transcutaneous Electrical Nerve Stimulation (TENS)
• Trastuzumab
• Utilization Management Resources | BlueCross BlueShield of Tennessee
• Vestronidase alfa-vjbk
• Ziv-Aflibercept
• Zoster Vaccine Recombinant, Adjuvanted

Click here to view the Blue Cross Blue Shield Tennessee Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.